To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).
Public ClinicalTrials.gov record NCT03731091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064% (Glenmark Pharmaceuticals Ltd) to the Marketed Product Enstilar® Foam (LEO Pharma Inc.) in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064% (Glenmark Pharmaceuticals Ltd) to the Marketed Product Enstilar® Foam (LEO Pharma Inc.) in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis)
Study identification
- NCT ID
- NCT03731091
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 494 participants
Conditions and interventions
Conditions
Interventions
- Calcipotriene/ betamethasone dipropionate topical foam, 0.005%/0.064% Drug
- Enstilar® foam (LEO Pharma Inc.) Drug
- Placebo of Calcipotriene/ betamethasone dipropionate topical foam Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2018 (Actual)
- Primary completion
- Mar 17, 2020 (Actual)
- Completion
- Mar 17, 2020 (Actual)
- Last update posted
- Aug 19, 2020
2018 – 2020
United States locations
- U.S. sites
- 30
- U.S. states
- 14
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site 20 | Encinitas | California | 92024 | — |
| Investigational Site 18 | Fountain Valley | California | 92708 | — |
| Investigational Site 19 | San Diego | California | 92108 | — |
| Investigational Site 15 | San Diego | California | 92123 | — |
| Investigational Site 23 | San Diego | California | 92123 | — |
| Investigational Site 17 | Santa Ana | California | 92705 | — |
| Investigational Site 22 | Santa Monica | California | 90404 | — |
| Investigational Site 29 | Clearwater | Florida | 33761 | — |
| Investigational Site 27 | Coral Gables | Florida | 33134 | — |
| Investigational Site 1 | Miami | Florida | 33144 | — |
| Investigational Site 26 | Pinellas Park | Florida | 33781 | — |
| Investigational Site 10 | New Albany | Indiana | 47150 | — |
| Investigational Site 3 | Overland Park | Kansas | 66215 | — |
| Investigational Site 16 | Louisville | Kentucky | 40241 | — |
| Investigational Site 21 | Saint Joseph | Missouri | 64506 | — |
| Investigational Site 12 | Henderson | Nevada | 89052 | — |
| Investigational Site 28 | New York | New York | 10019 | — |
| Investigational Site 4 | High Point | North Carolina | 27262 | — |
| Investigational Site 24 | Wilmington | North Carolina | 28405 | — |
| Investigational Site 8 | Beachwood | Ohio | 44122 | — |
| Investigational Site 2 | Cincinnati | Ohio | 45246 | — |
| Investigational Site 13 | Greenville | South Carolina | 29607 | — |
| Investigational Site 7 | Knoxville | Tennessee | 37922 | — |
| Investigational site 31 | Murfreesboro | Tennessee | 37130 | — |
| Investigational Site 25 | Nashville | Tennessee | 37215 | — |
| Investigational Site 5 | Austin | Texas | 78759 | — |
| Investigational Site 11 | San Antonio | Texas | 78213 | — |
| Investigational Site 14 | San Antonio | Texas | 78249 | — |
| Investigational Site 30 | Webster | Texas | 77598 | — |
| Investigational Site 6 | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03731091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2020 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03731091 live on ClinicalTrials.gov.